A Randomised Controlled Trial Of Deprescribing To Optimise Medical Therapy For Frail Older People: The Opti-Med Study.
Funder
National Health and Medical Research Council
Funding Amount
$1,444,996.00
Summary
Many older people living in residential aged care facilities (RACF) are prescribed medications of uncertain benefit. The primary aim of the Opti-med study is to determine the safety and benefits of reducing the number of medications prescribed to frail older people in RACF. We will withdraw as many medications as possible from participants in the intervention group. Our study will provide randomised controlled data on the safety and efficacy of ceasing medications in frail older people.
Why Is There An Increased Risk Of Severe Adverse Perinatal Outcomes After The Use Of Clomiphene Citrate For Infertility Treatment?
Funder
National Health and Medical Research Council
Funding Amount
$570,065.00
Summary
Clomiphene citrate (CC) has been a first line treatment for female infertility internationally since the 1960’s. However, safety studies using routine prescribing practices were never performed, and numerous data sources now indicate that CC is associated with major adverse outcomes if the fetus is inadvertently exposed. We are linking prescription data to perinatal outcomes to confirm how CC is associated with adverse events so as to inform prescriber and practice change.
Understanding Health Service System Needs For People With Intellectual Disability
Funder
National Health and Medical Research Council
Funding Amount
$1,216,389.00
Summary
The health of people with intellectual disability (ID) is one of the poorest of any group in Australia. People with ID experience higher rates of ill health, poor access to responsive health services and premature death. Our research will develop the first comprehensive profile of health, health service and medicines use and costs for people with ID, and will examine the impact of the National Disability Insurance Scheme (NDIS) on these metrics.
Pharmaceutical Opioid Prescription For Chronic Pain In Australia: Trajectories Of Prescribing, Risk Of Adverse Events, And Predictors Of Harm
Funder
National Health and Medical Research Council
Funding Amount
$1,086,274.00
Summary
There is concern about rising levels of opioid analgesic prescribing in Australia. This study is important because it will provide evidence about long term outcomes for patients using opioid therapy for chronic non-malignant pain. It will examine prescribing patterns and link them to other health outcomes such as overdose. We will also study patients beginning opioid therapy for chronic pain and follow them up over 2 years to examine outcomes such as pain relief and medication side effects.
Long-Term Use And Cost-Effectiveness Of Secondary Prevention Medications For Heart Disease In Western Australian Seniors
Funder
National Health and Medical Research Council
Funding Amount
$760,525.00
Summary
Clinical trials show that long-term treatment with selected medicines greatly reduces the risk of further heart attacks or stroke in persons with known heart disease. Levels of such prescribing is high when patients are discharged from hospital, but the extent to which patients continue with long-term treatment is unknown. We will investigate compliance with treatment, and the costs and effectiveness of these medicines in a population study of patients aged 65 years or more in Western Australia.